Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Search ...
February 2022
Smartphone App Used to Reduce Depressive Symptoms in Patients with Comorbidities in Low- and Middle-Income Countries
Depression
February 2022
Six weeks of 10-minute sessions using a smartphone app reduced depressive symptoms in patients with diabetes or hypertension in Brazil and Peru, according to 2 recent randomized clinical trials.
Read More
Comparison of Relapse Rates for Disease-Modifying Therapies for Multiple Sclerosis Using Real-World Data
Multiple Sclerosis
February 2022
A comparative effectiveness study of real-world data from patients with multiple sclerosis showed that dimethyl fumarate and fingolimod were equivalent and rituximab was superior to natalizumab for reducing relapse.
Read More
Classifying Migraine Subtypes
Migraine
February 2022
Migraines may be classified into 3 subtypes based on headache intensity, frequency, and the presence of photophobia and phonophobia, according to a new analysis.
Read More
Sleep Depth May Be Correlated with Heart Rate After Seizures During Sleep
Epilepsy
February 2022
For seizures that occur during sleep, deeper sleep in the 5 minutes preceding a seizure was correlated with a reduced heart rate after the seizure, according to a recent study.
Read More
Relapse in Patients with Dementia-Related Psychosis After Discontinuation of Pimavanserin
Alzheimer’s Disease/Dementia
February 2022
Discontinuation of pimavanserin for dementia-related psychosis was associated with a higher rate of relapse compared with continuation, according to a recent randomized discontinuation trial that was stopped early for efficacy.
Read More
Search ...
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Subscribe to
Value-Based Care in Neurology
Stay up to date with personalized medicine by subscribing to receive the free
VBCN
e‑Newsletter.
I'd like to receive:
VBCN
e‑Newsletter
I have reviewed and consent to the terms of
VBCN
's
Privacy Policy
, and
VBCN
has my permission to retain my information in its database, and to forward pertinent communications to me.